Saba Capital Files 13D for abrdn Healthcare Investors
Ticker: HQH · Form: SC 13D · Filed: Mar 15, 2024 · CIK: 805267
| Field | Detail |
|---|---|
| Company | Abrdn Healthcare Investors (HQH) |
| Form Type | SC 13D |
| Filed Date | Mar 15, 2024 |
| Risk Level | medium |
| Pages | 8 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.01, $41,875,746 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 13D-filing, activist-investor, ownership-change
TL;DR
**SABA CAPITAL TAKES STAKE IN ABRDN HEALTHCARE INVESTORS**
AI Summary
Saba Capital Management, L.P. has filed a Schedule 13D on March 15, 2024, indicating a change in beneficial ownership of abrdn Healthcare Investors. The filing details Saba Capital's holdings and intentions regarding the issuer's common shares.
Why It Matters
This filing signals a significant investor's stake and potential influence over abrdn Healthcare Investors, which could impact the company's strategic direction or shareholder value.
Risk Assessment
Risk Level: medium — Schedule 13D filings often precede activist campaigns or significant strategic shifts, introducing uncertainty for the issuer and its shareholders.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Filing entity
- abrdn Healthcare Investors (company) — Subject company
- Boaz R. Weinstein (person) — Group member of Saba Capital Management
- Micha (person) — Contact person at Saba Capital Management
FAQ
What is the primary purpose of this Schedule 13D filing?
The primary purpose is to report a change in beneficial ownership of abrdn Healthcare Investors by Saba Capital Management, L.P.
Who is the filing entity and who is the subject company?
The filing entity is Saba Capital Management, L.P., and the subject company is abrdn Healthcare Investors.
When was this filing made?
The filing was made on March 15, 2024.
What is the CUSIP number for abrdn Healthcare Investors' common shares?
The CUSIP number is 87911J103.
What is the business address of Saba Capital Management, L.P.?
The business address is 405 Lexington Avenue, 58th Floor, New York, NY 10174.
Filing Stats: 2,404 words · 10 min read · ~8 pages · Grade level 13.5 · Accepted 2024-03-15 10:47:24
Key Financial Figures
- $0.01 — stors (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securitie
- $41,875,746 — ported herein. A total of approximately $41,875,746 was paid to acquire the Common Shares r
Filing Documents
- formsc13d.htm (SC 13D) — 70KB
- exhibit1.htm (EX-1) — 4KB
- 0001062993-24-006470.txt ( ) — 76KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: March 15, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 87911J103 SCHEDULE 13D Page 10 of 10 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 1/16/2024 Buy 41,663 17.28 1/26/2024 Buy 126,927 16.97 1/29/2024 Buy 41,071 16.99 1/30/2024 Buy 45,720 17.15 1/31/2024 Buy 66,096 17.20 2/1/2024 Buy 5,534 17.30 2/2/2024 Buy 98,276 17.28 2/7/2024 Buy 121,237 17.31 2/8/2024 Buy 42,062 17.15 2/9/2024 Buy 40,961 17.12 2/13/2024 Buy 26,123 17.39 3/11/2024 Buy 7,570 16.96 3/12/2024 Buy 44,098 16.94 3/13/2024 Buy 49,657 17.03